Characterization of Potential Biomarkers of Eye Disease and Vision

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-09-30

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal

NCT02748824

Age-Related Macular Degeneration

COMPLETED

10-year Progression of Diabetic Retinopathy: Identification of Signs and Surrogate Outcomes

NCT04650165

Diabetic Retinopathy

COMPLETED

Characterization of Early Markers of Choroidal Neovascularization

NCT00801541

Age-related Macular Degeneration

COMPLETED

Metabolomics: A Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration

NCT04241536

Age-related Macular Degeneration

COMPLETED NA

Biomarkers of Common Eye Diseases

NCT04101604

Uveitis Diabetic Retinopathy Age-related Macular Degeneration +3 more

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a registry study. Only patients followed under the clinical practice at AIBILI Clinical Trial Centre, and with a signed informed consent form will be included.

Based on the clinical information collected under the clinical practice, and based on patients' characteristics, scientific questions will be raised and data will be collected and analysed accordingly.

Any procedure performed under clinical practice that may allow for the characterization of the disease and/or for the identification of potential biomarkers will be collected and analysed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eye Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any patient followed under the normal clinical practice at AIBILI Clinical Trial Centre, and with a AIBILI signed informed consent form for data collection, Imp. 11-7-2 "Consentimento Informado para tratamento de dados".